Results 191 to 200 of about 42,546 (247)
Cannabis sativa phytochemicals in cancer therapy: molecular mechanisms and therapeutic potential. [PDF]
Montle R, More GK, Takaidza S, Mtunzi F.
europepmc +1 more source
Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities. [PDF]
Li H +8 more
europepmc +1 more source
Inhibition of Monoacylglycerol Lipase Suppresses Lipopolysaccharide-Enhanced Melanoma Proliferation and Migration. [PDF]
Almutairi F +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Cannabinoid CB1 Receptor in Schizophrenia
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2021Converging lines of evidence from epidemiological, preclinical, and experimental studies indicate that the endocannabinoid system may be involved in the pathophysiology of schizophrenia and suggest that the cannabinoid CB1 receptor may be a potential therapeutic target.
Faith Borgan +2 more
openaire +3 more sources
2022
Type-1 cannabinoid receptor (CB1), one of the main targets of endocannabinoids, plays a key role in several pathophysiological conditions that affect both the central nervous system and peripheral tissues. Today, its biochemical identification and pharmacological characterization, as well as the screening of thousands of novel ligands that might be ...
Gasperi V, Savini I, Catani MV
openaire +3 more sources
Type-1 cannabinoid receptor (CB1), one of the main targets of endocannabinoids, plays a key role in several pathophysiological conditions that affect both the central nervous system and peripheral tissues. Today, its biochemical identification and pharmacological characterization, as well as the screening of thousands of novel ligands that might be ...
Gasperi V, Savini I, Catani MV
openaire +3 more sources
Behavioural Pharmacology, 2005
It is well established that Cannabis sativa can increase appetite, particularly for sweet and palatable foods. In laboratory animals, cannabinoid CB1 receptor antagonism decreases motivation for palatable foods, and most recently, the CB1 receptor antagonist SR141716A, or rimonabant (Acomplia), was reported to produce weight loss in obese human ...
S J, Ward, L A, Dykstra
openaire +2 more sources
It is well established that Cannabis sativa can increase appetite, particularly for sweet and palatable foods. In laboratory animals, cannabinoid CB1 receptor antagonism decreases motivation for palatable foods, and most recently, the CB1 receptor antagonist SR141716A, or rimonabant (Acomplia), was reported to produce weight loss in obese human ...
S J, Ward, L A, Dykstra
openaire +2 more sources

